# Why Bitcoin for Canurta

**Published by:** [Canurta.eth](https://paragraph.com/@canurta/)
**Published on:** 2025-05-24
**URL:** https://paragraph.com/@canurta/why-bitcoin-for-canurta

## Content

By Akeem Gardner, CEO & Founder, Canurta TherapeuticsAt Canurta, we’ve never followed convention for convention’s sake. We’re building a new blueprint for how biotech companies can scale — one that prioritizes financial resilience, founder-led execution, and long-term shareholder value. That’s why we’re anchoring our capital strategy to Bitcoin. This is not a gimmick. It’s a deliberate financial move that increases our purchasing and R&D power by 30–60% ARR and positions us to lead institutional biotech innovation in Canada with asymmetric upside and limited downside. We're creating the first adaptive medicine company backed by Bitcoin reserves — and with it, a new playbook for the capital markets.Why BitcoinStrengthens Capital Efficiency By integrating Bitcoin into our treasury model:We gain exposure to an appreciating reserve assetWe minimize dilution by accessing BTC-backed financing toolsWe enable strategic rebalancing to meet investor needs during volatilityEnables Optionality Without Fragility With regulated Canadian OTC access and margin lending partners, we can:Sell or collateralize BTC as needed, without relying on banksFund trials, operations, or acquisitions with non-dilutive capitalMaintain a steady NAV anchor (3:1) to issue optional securities if desiredAligns with Institutional Trends With FASB guidance and growing institutional adoption, BTC is no longer fringe — it’s part of the future. This gives Canurta a chance to front-run a shift in capital formation and stand out as an institutional-grade biotech that operates with the prudence of a sovereign investor.Rethinking RiskAs Warren Buffett said:“Risk is not volatility, but permanent loss of capital.”We agree. Volatility is not the enemy — poor execution is. Bitcoin offers volatility, yes — but also resilience, transparency, and global liquidity. By contrast, the permanent loss of purchasing power in fiat currencies, especially the USD, is the silent risk that most overlook.What It Takes to WinExecuting a strategy like this requires:Courage from the founderGoodwill from the teamTrust from our investorsAnd most importantly: results. We're not asking to be believed — we're asking to be measured. Canurta’s team is here to execute.The Broader Vision: Advancing Canadian Capital MarketsOur ambition goes beyond Canurta. We believe Canada can be a global leader in BTC-backed biotech finance. We're building this strategy not just for ourselves, but for:CanadianMunicipalities, like Vancouver, with forward-thinking financial structuresCorporations and SMEs looking to access resilient, modern capitalBoards of Trade and innovation councils who can champion resilient business models across the countryThis isn’t theory — it’s a testable, repeatable path. One step at a time, using open-source tools, transparency, and results.The “Holy Grail” of Finance: Uncorrelated AlphaBitcoin gives us what traditional portfolios struggle to find: An uncorrelated asset that improves risk-adjusted returns. We manage volatility through:Position sizing and drawdown strategiesKeeping our mind on long time horizons that allow us to ride macro cyclesQuarterly rebalancing and capital rotation disciplineClosing ThoughtMarkets reward clarity and courage.We’re not chasing trends — we’re setting the terms. BTC gives Canurta the freedom to execute without surrendering control. It strengthens our balance sheet, hedges systemic risk, and creates a durable advantage for our shareholders — one that compounds over time. We're not here to play defense. We're here to win. Let’s build the future of medicine — backed by the future of money. Akeem Gardner | CEO & Founder | Canurta Therapeutics | akeem@canurta.com

## Publication Information

- [Canurta.eth](https://paragraph.com/@canurta/): Publication homepage
- [All Posts](https://paragraph.com/@canurta/): More posts from this publication
- [RSS Feed](https://api.paragraph.com/blogs/rss/@canurta): Subscribe to updates